Prospective Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Orthop. Aug 18, 2022; 13(8): 760-767
Published online Aug 18, 2022. doi: 10.5312/wjo.v13.i8.760
Quantitative alpha-defensin testing: Is synovial fluid dilution important?
Rodrigo Calil Teles Abdo, Riccardo Gomes Gobbi, Chilan Bou Ghosson Leite, Sandra Gofinet Pasoto, Elaine Pires Leon, Ana Lucia Lei Munhoz Lima, Eloisa Bonfa, José Ricardo Pécora, Marco Kawamura Demange
Rodrigo Calil Teles Abdo, Riccardo Gomes Gobbi, Chilan Bou Ghosson Leite, Ana Lucia Lei Munhoz Lima, José Ricardo Pécora, Marco Kawamura Demange, Instituto de Ortopedia e Traumatologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo 05403-010, Brazil
Rodrigo Calil Teles Abdo, Riccardo Gomes Gobbi, Orthopaedic Department, HCor - Hospital do Coração, Sao Paulo 04004-030, Brazil
Sandra Gofinet Pasoto, Elaine Pires Leon, Eloisa Bonfa, Division of Rheumatology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo 05403-010, Brazil
Author contributions: Abdo RCT collected the samples; Leite CBG wrote the article; Abdo RCT, Leite CBG, Lima ALLM and Bonfa E contributed to the data analysis; Abdo RCT, Gobbi RG, Lima ALLM, Bonfa E, Pécora JR and Demange MK contributed to the intellectual concept and design of the study; Pasoto SG performed the laboratory tests and contributed to the strategy for alpha-defensin analysis according to its dilution; Leon EP conducted the laboratory tests; Gobbi RG reviewed the article.
Supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), No. 2017/25540-9.
Institutional review board statement: The study was approved by the local Institutional Review Board, No. 71039317.3.0000.0068.
Informed consent statement: All study participants, or their legal guardian, provided written consent prior to study enrollment.
Conflict-of-interest statement: All authors report no relevant conflict of interest for this article.
Data sharing statement: There is no additional data available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Rodrigo Calil Teles Abdo, MD, Surgeon, Instituto de Ortopedia e Traumatologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, R. Dr. Ovídio Pires de Campos, 333 - Cerqueira César., Sao Paulo 05403-010, Brazil. rctabdo@gmail.com
Received: October 15, 2021
Peer-review started: October 15, 2021
First decision: January 11, 2022
Revised: February 4, 2022
Accepted: August 5, 2022
Article in press: August 5, 2022
Published online: August 18, 2022
Processing time: 304 Days and 21.2 Hours
Core Tip

Core Tip: Alpha-defensin is an antimicrobial peptide widely studied in patients with periprosthetic joint infection. Indeed, the analysis of alpha-defensin concentration in the synovial fluid by enzyme-linked immunosorbent assay (ELISA) has been gaining ground. However, there is a lack of information regarding the detailed technique for synovial fluid ELISA, particularly in regard to its dilution. Therefore, this study analyzed the influence of dilution in synovial fluid samples for the alpha-defensin ELISA method. We presume that this novel information may be helpful to make ELISA more reproducible and widely accessible for different treatment centers worldwide.